(Q53166962)

English

Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

1 reference

based on heuristic

inferred from title

Acute myeloblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

M Robin

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

G F Sanz

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

I Ionescu

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

B Rio

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

A Sirvent

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

M Renaud

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

E Carreras

7

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

N Milpied

8

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

M Mohty

9

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

Y Beguin

10

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

P Bordigoni

11

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

T de Witte

12

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

A Picardi

13

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

D Purtill

14

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

E Gluckman

15

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

N Kroger

16

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

V Rocha

17

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

publication date

30 September 2010

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

25

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

75-81

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

https://scigraph.springernature.com/pub.10.1038/leu.2010.219

0 references

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

21 January 2018

Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.219

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/20882048

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53166962&oldid=1534633642"